Erlotinib after initial platinum-doublet chemotherapy in patients with epidermal growth factor receptor (EGFR) wild-type (WT) non-small cell lung cancer (NSCLC): Results of a combined patient-level analysis of the BR.21 and SATURN trials.
Raymond U Osarogiagbon
Consultant or Advisory Role - Astellas Pharma; Pfizer; Roche
Honoraria - Astellas Pharma; Pfizer; Roche
Federico Cappuzzo
Consultant or Advisory Role - Roche (U)
Tudor-Eliade Ciuleanu
Consultant or Advisory Role - OSI Pharmaceuticals; Roche
Honoraria - OSI Pharmaceuticals; Roche
Larry Leon
Employment or Leadership Position - Genentech
Stock Ownership - Genentech